Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Future Cardiology|February 9, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CMNitasha Sarswat, Amrut V Ambardekar, Kevin M Alexander, et al.
Journal of the American College of Cardiology|December 17, 2025
Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health AdministrationGabriela Spencer-Bonilla, Jun Fan, Paul Cheng, et al.
Heart Failure Reviews|January 12, 2021
Challenges and the innovations in the care of advanced heart failure patients during COVID-19Amin Yehya, Kevin S Shah, Sumeet S Mitter, et al.
Circulation|November 10, 2025
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled TrialMarianna Fontana, Pablo Garcia-Pavia, Martha Grogan, et al.
Journal of the American Heart Association|November 3, 2025
Dual Contrast-Enhanced Microcomputed Tomography Uncovers Leaflet-Dependent Patterns of Macrocalcification, Fibrous Extracellular Matrix Remodeling, and Adipocyte Degeneration in Calcific Aortic StenosisMustapha El Zeini, Ines Ross Tacco, John I Jimenez, et al.
American Heart Journal|September 14, 2025
Developing therapeutics for rare cardiovascular diseasesJoseph B Lerman, Dwight D Koeberl, Shilpi Epstein, et al.
Journal of the American Heart Association|May 30, 2026
Association Between Predicting Risk of Cardiovascular Disease Events (PREVENT) Risk Scores and Subclinical Cardiovascular Disease: Insights From the Project Baseline Health StudyGracia Fahed, Diona Gjermeni, Nicholas Cauwenberghs, et al.
Heart Rhythm|August 3, 2026
Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy: Mechanisms, Prognostic Implications, and ManagementAaryamaan Verma, Kushal Chatterjee, Jiaqi Li, et al.
JAMA Cardiology|February 23, 2022
High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep LearningGrant Duffy, Paul P Cheng, Neal Yuan, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Pageof 8